|
|
||||||||
Cutting Edge |



*
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104;
Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892;
Medical Research Council Center for Immune Regulation, School of Medicine, University of Birmingham, Edgbaston, Birmingham, U.K.; and
Department of Medicine, CornellDivision of Immunology, Cornell University Medical College, New York, NY 10021
| Abstract |
|---|
|
|
|---|
B family of transcription factors, is essential for
LPS-induced IL-12p40 production by macrophages. In this study, we
demonstrate that c-Rel is also required for IL-12p40 production by
macrophages in response to Corynebacterium parvum, CpG
oligodeoxynucleotides, anti-CD40 and low molecular weight
hyaluronic acid. However, c-Rel-/- mice infected with
Toxoplasma gondii produce comparable amounts of IL-12p40
to infected wild-type mice and have an IL-12-dependent mechanism of
resistance to this infection. Furthermore, c-Rel was not required for
IL-12p40 production by macrophages or dendritic cells in response to
soluble Toxoplasma Ag, and neutrophils from
c-Rel-/- mice contain normal amounts of preformed
IL-12p40. Together these studies reveal the presence of c-Rel-dependent
pathways critical for IL-12p40 production in response to inflammatory
stimuli and demonstrate a novel c-Rel-independent pathway of IL-12p40
production during toxoplasmosis. | Introduction |
|---|
|
|
|---|
during
the innate and adaptive immune response to many different viral,
bacterial, and parasitic infections (1). Many of the
microbial products which stimulate the innate production of IL-12 from
accessory cells such as macrophages and dendritic cells
(DC)3 signal through
Toll-like receptors (TLR) which activate the NF-
B family of
transcription factors (2, 3, 4). The NF-
B family of
transcription factors includes p65 (RelA), RelB, c-Rel, p50, and p52.
Several studies have indicated the importance of NF-
B in the
regulation of IL-12 production (5, 6, 7, 8), consistent with the
role of NF-
B as an important regulator of innate responses. More
recent studies have suggested that of these family members, only c-Rel
is critical for the ability of LPS to stimulate macrophages to produce
IL-12, although c-Rel is not required for their ability to produce
TNF-
, IL-6, or NO (9). These previous studies are
important because they place c-Rel at a critical point in the innate
response that leads to the production of IL-12 following stimulation
with Gram-negative bacteria. However, as discussed by Sanjabi et al.
(9), the biological significance of the c-Rel requirement
for IL-12p40 expression is unknown. The studies presented here
demonstrate that c-Rel is essential for the ability of macrophages to
produce IL-12 in response to numerous proinflammatory stimuli in vitro
and in vivo, but identify a c-Rel-independent pathway for the
production of IL-12 following infection with the parasite
Toxoplasma gondii. These results suggest the presence of
alternative pathways for the innate recognition of T. gondii
that are distinct from the TLR pathways that have been implicated in
the innate recognition of bacterial, fungal, parasitic, and viral
infections (10). | Materials and Methods |
|---|
|
|
|---|
Wild-type (WT) C57BL/6 mice (age 68 wk) were obtained from The Jackson Laboratory (Bar Harbor, ME). C57BL/6 c-Rel-deficient (c-Rel-/-) mice were originally obtained from H. C. Liou and bred within the University Laboratory Animal Resources facility of the University of Pennsylvania. Age- and sex-matched mice were inoculated i.p. with either 100 µg of Salmonella minnesota-derived LPS (Sigma-Aldrich, St. Louis, MO) in sterile PBS, 25 µg of soluble Toxoplasma Ag lysate (STAg) or 200 µg of anti-CD40 (R&D Systems, Minneapolis, MN). STAg was prepared from in vitro-cultured tachyzoites of T. gondii strain RH as previously described (11). For live infections, age- and sex-matched WT and c-Rel-/- mice were inoculated orally with 20 cysts of the ME49 strain of T. gondii or i.p. with 10,000 tachyzoites of the RH strain of T. gondii.
Preparation of macrophages and DC
Bone marrow-derived macrophages (BMM
) were prepared as
previously described (12). Peritoneal macrophages were
elicited using 1 ml of 10% thioglycolate (TG) injected i.p., and cells
were harvested 72 h later. Cell purity was assessed by cytospin
analysis and >98% of cells were found to be macrophages.
CD11c+ splenic DC were positively selected from
collagenase D-digested spleens using MACS Separation Beads (CD11c
MicroBeads; Miltenyi Biotec, Auburn, CA). Isolated cell purity was
assessed by FACS analysis and routinely found to be 8590%. For
stimulation, BMM
were incubated at 37°C in 5%
CO2 for 72 h with LPS (250 ng/ml,
Sigma-Aldrich), C. parvum (10 µg/ml; Trudo Institute,
Saranac Lake, NY), CpG containing oligodeoxynucleotides (ODN; 1
µg/ml), soluble anti-CD40 (15 µg/ml; R&D Systems, Minneapolis,
MN), low molecular weight hyaluronic acid (LMW-HA, 100 µg/ml;
Sigma-Aldrich), or STAg (25 µg/ml). The ODN used in this study was
the CpG containing phosphorothioate backbone oligonucleotide 1826 (TCC
ATG ACG TTC CTG ACG TT) (synthesized by the University of Pennsylvania
Veterinary DNA facility). The stimulants C. parvum, CpG-ODN,
soluble anti-CD40, LMW-HA, and STAg were pretreated with 10 µg/ml
polymixin B (Sigma-Aldrich) to ensure that any LPS contamination would
not contribute to IL-12 production by macrophages. Supernatants were
harvested and the production of IL-12p40 and IL-6 was measured using
ELISAs as previously described (12). Levels of reactive
nitrogen intermediates were measured using the Greiss assay as
previously described (13).
Flow cytometric analysis
CD11c+ splenic DC from infected mice or
mice injected with STAg were cultured overnight with 25 µg/ml STAg or
media, respectively, plus 10 µg/ml brefeldin A (Sigma-Aldrich). Cell
suspensions were then incubated with Abs against CD11c and CD8
,
before staining for intracellular IL-12p40, as previously described
(14). Peritoneal cells were harvested from infected mice
and stained with anti-Gr-1 or isotype control and IL-12p40 as
previously described (15). Cells were immediately recorded
on a FACS-Calibur flow cytometer (BD Biosciences, Mountain View, CA)
and analyzed with CellQuest software (BD Biosciences). One hundred
thousand events were recorded for each sample.
| Results |
|---|
|
|
|---|
Previous studies demonstrated an essential role for c-Rel in
the ability of macrophages stimulated with LPS to produce IL-12p40
(9). Since there are alternative stimuli which can induce
macrophages to produce high levels of IL-12 (16, 17, 18, 19),
studies were performed to determine whether there was a
stimulus-specific requirement for c-Rel in the production of IL-12p40.
BMM
and TG-elicited peritoneal macrophages from WT and
c-Rel-/- mice were stimulated with LPS, LMW-HA,
CpG containing ODN, anti-CD40, or C. parvum for 72
h and the levels of IL-12p40 produced in the supernatants were measured
by ELISA. BMM
and TG-elicited peritoneal exudate cells (PECs) from
c-Rel-/- mice were deficient in the production
of IL-12p40 in response to all of the stimuli used (Fig. 1
, A and B).
Furthermore, WT and c-Rel-/- macrophages
produced comparable levels of IL-6 and NO in these cultures (data not
shown). These data confirm previous studies that c-Rel is essential for
LPS-induced production of IL-12p40, which is mediated through TLR4, and
extend these studies to show that the production of IL-12p40 mediated
through TLR2, TLR9, CD40, and CD44 is also dependent on c-Rel.
|
c-Rel-independent IL-12 production mediates resistance to T. gondii
The production of IL-12 is essential for the development of
resistance to many intracellular pathogens including T.
gondii. Thus, mice infected with T. gondii and treated
with Abs to deplete IL-12 or that lack the capacity to produce or
respond to IL-12 are highly susceptible to toxoplasmosis and succumb to
infection within1014 days (20, 21, 22). To determine
whether c-Rel is necessary for the production of IL-12 in response to
this infection, c-Rel-/- mice were infected
orally with 20 cysts of T. gondii and serum levels of
IL-12p40 were measured 5 and 7 days after infection. Surprisingly,
c-Rel-/- mice produced comparable levels of
IL-12p40 to WT mice at both time points (Fig. 2
A). Infected mice survived
for 67 wk, suggesting that an IL-12-dependent mechanism of resistance
to T. gondii exists in c-Rel-/-
mice. This was confirmed by studies in which
c-Rel-/- mice treated with anti-IL-12 at
the time of infection died within 1014 days (Fig. 2
B).
These studies demonstrate that in c-Rel-/- mice
infected with T. gondii there is a mechanism that allows
normal production of IL-12 which provides protection against this
infection.
|
Macrophages (23), DC (24), and
neutrophils (25) have all been shown to be sources of
IL-12p40 in different models of Toxoplasma-induced
production of IL-12. Therefore, several defined experimental systems
were used to examine the capacity of these different cell types to
produce IL-12p40 in response to T. gondii. As previously
described (23), the stimulation of TG-elicited macrophages
from WT mice with STAg led to the production of IL-12p40. In contrast
to the results obtained with other stimuli, when TG-elicited
macrophages from c-Rel-/- mice were stimulated
with STAg they produced comparable levels of IL-12p40 to WT (Fig. 3
A) and similar results were
obtained using BMM
(data not shown).
|
+
DC in the spleen (14, 24). To determine whether DC
production of IL-12 in response to T. gondii is c-Rel
dependent, WT and c-Rel-/- mice were injected
i.p. with STAg, and the systemic levels of IL-12p40 were measured
6 h later and intracellular staining for IL-12p40 was performed on
splenic DC. In these studies, the systemic levels of IL-12p40 produced
after injection of STAg were comparable (WT = 8.855 ng/ml ±
3.2; c-Rel-/- = 13.7885 ng/ml ± 6.3;
three mice in each group; similar results were obtained in four
separate experiments). FACS analysis revealed that although there were
no IL-12p40+ DC from control mice, the injection
of STAg resulted in the emergence of a population of
CD8
+ DC that were positive for IL-12p40 and
this was similar in WT and c-Rel-/- mice (Fig. 3
+ and CD8
-
splenic DC contained IL-12p40
(CD8
+CD11c+ WT, 18.56%;
c-Rel-/-, 13.93%;
CD8
-CD11c+ WT, 6.51%;
c-Rel-/-, 4.44%,) and that the levels of
IL-12p40 produced by these cells were comparable (data not shown).
Neutrophils have recently been shown to contain preformed stores of
IL-12 (15, 26) and have been identified as an important
source of IL-12 during the early immune response to infection with
T. gondii (25). To determine whether
neutrophils require c-Rel for the production of IL-12p40, the approach
described by Denkers and colleagues (15) was used.
WT and c-Rel-/- mice were infected i.p. with
the RH strain of T. gondii and PECs were harvested 4 h
later and flow cytometry was used to analyze granulocytes
(Gr-1+ cells) for the presence of intracellular
IL-12p40. As shown in Fig. 3
C, similar numbers of
Gr-1+IL-12p40+ cells were
observed in samples from WT and c-Rel-/- mice.
Thus, c-Rel is not required for the ability of neutrophils to produce
preformed stores of IL-12p40.
| Discussion |
|---|
|
|
|---|
B site
in the IL-12p40 promoter (9). However, only c-Rel has been
shown to be essential for the LPS-induced signaling through TLR4 that
leads to the production of IL-12p40 by macrophages (9).
The studies reported here extend these findings to include an essential
role for c-Rel in IL-12p40 production by macrophages in response to
C. parvum, CpG containing ODN, anti-CD40, and LMW-HA
which signal through TLR2, TLR9, CD40, and CD44, respectively
(16, 17, 18, 19). TLR are strongly implicated in innate immune
recognition and are thought to activate NF-
B via a common pathway
(4). Signaling through CD40 and CD44 have also been shown
to activate NF-
B (27, 28), and the studies presented
here demonstrate a role for c-Rel in their ability to induce IL-12.
Thus, together these data place c-Rel at a critical point in innate,
TLR-mediated production of IL-12 and indicate that c-Rel is likely to
be involved in the regulation of macrophage production of IL-12 during
inflammation with consequences for the nature of the subsequently
elicited adaptive immune response.
Given the important role of c-Rel in the regulation of innate
production of IL-12, the finding that c-Rel-/-
mice infected with T. gondii produced normal levels of IL-12
and had an IL-12-dependent mechanism of resistance was surprising. The
studies presented here demonstrate that the ability of macrophages and
neutrophils to respond to T. gondii and produce
IL-12p40 is independent of c-Rel. In addition, our finding that
CD8
+ DC can produce IL-12p40 in a
c-Rel-independent manner is in agreement with the recent findings of
Grumont et al. (29). Interestingly, these studies also
demonstrated that c-Rel is required for the TLR-mediated production of
p35 by CD8
+ DC (29), suggesting
that c-Rel-/- DC produce only inhibitory p40
homodimers and monomers. However, since IL-12p70 is required for
resistance to T. gondii, the finding that
c-Rel-/- mice survive the acute phase of
toxoplasmosis indicates that c-Rel-independent production of IL-12p35
occurs in mice challenged with T. gondii.
Together, these results suggest the presence of an alternative pathway
for the innate recognition of T. gondii and production of
IL-12 in response to this parasite that is distinct from the
Toll-mediated, NF-
B-dependent pathways that have been implicated in
the innate recognition of bacterial, fungal, parasitic, and viral
infections (1). Support for this conclusion is provided by
studies in which mice deficient in NF-
B1,
NF-
B2, or RelB can produce normal levels of
IL-12 when infected with T. gondii (12, 30).
Furthermore, recent studies have shown that STAg or infection of cells
with T. gondii does not induce activation of NF-
B and
that this parasite inhibits the ability of infected cells to activate
NF-
B in response to LPS (31, 32). However, some
pathways that lead to the production of IL-12 in response to LPS and
T. gondii are shared, since IFN consensus sequence-binding
protein, an IFN regulatory factor family member, is required for
the production of IL-12 in response to both of these stimuli (33, 34). Since there are a number of intracellular pathogens that
evade or actively inhibit activation of NF-
B (35, 36),
the identification of a c-Rel-independent pathway for IL-12 production
indicates the presence of a unique innate response that allows the
development of protective immunity to these pathogens. This
c-Rel-independent pathway of IL-12 production may be activated
following the engagement of a TLR, but the downstream signaling pathway
may be distinct from that observed with TLR2, TLR4, and TLR9.
Alternatively, innate recognition of T. gondii and its
components may occur through a novel receptor that induces production
of IL-12 independently of NF-
B.
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Christopher A. Hunter, Department of Pathobiology, University of Pennsylvania, 3800 Spruce Street, Philadelphia, PA 19104-6008. E-mail address: chunter{at}phl.vet.upenn.edu ![]()
3 Abbreviations used in this paper: DC, dendritic cell; STAg, soluble Toxoplasma Ag; LMW-HA, low molecular weight hyaluronic acid; WT, wild type; TLR, Toll-like receptor; BMM
, bone marrow-derived macrophage; TG, thioglycolate; PEC, peritoneal exudate cell. ![]()
Received for publication November 26, 2001. Accepted for publication January 22, 2002.
| References |
|---|
|
|
|---|
B activation: a phylogenetically conserved paradigm in innate immunity. J. Clin. Invest. 107:13.[Medline]
B and Ets transcription factors in Epstein-Barr virus- transformed B cells and macrophages. J. Biol. Chem. 273:6431.
B half- site. Mol. Cell. Biol. 15:5258.[Abstract]
receptor ligation. J. Immunol. 166:4498.
B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:4453.
interferon and other cytokines in suppression of the spleen cell proliferative response to concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infect. Immun. 63:751.[Abstract]
+ dendritic cells. Nat. Immunol. 1:83.[Medline]
in IL-12-deficient mice during Toxoplasma gondii infection. J. Immunol. 162:5449.
by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90:6115.
-independent IL-12. J. Immunol. 163:2081.
B. Eur. J. Immunol. 27:3461.[Medline]
B/I-
B
autoregulatory loop in murine macrophages. J. Exp. Med. 183:2373.
B2 in the regulation of apoptosis and in maintenance of T cell-mediated immunity to Toxoplasma gondii. J. Immunol. 165:5720.
B activation by infection with
Toxoplasma gondii. J. Infect. Dis. 185:566.
B. J. Immunol. 167:2193.
-inducible transcription factor, IFN consensus sequence binding protein (ICSBP), stimulates IL-12 p40 expression in macrophages. J. Immunol. 165:271.
B-
ubiquitination. Science 289:1560.
B function. J. Immunol. 163:3928.This article has been cited by other articles:
![]() |
Y.-C. Lu, I. Kim, E. Lye, F. Shen, N. Suzuki, S. Suzuki, S. Gerondakis, S. Akira, S. L. Gaffen, W.-C. Yeh, et al. Differential Role for c-Rel and C/EBP{beta}/{delta} in TLR-Mediated Induction of Proinflammatory Cytokines J. Immunol., June 1, 2009; 182(11): 7212 - 7221. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Y. Stokes, L. Calahan, C. M. Hamric, J. M. Russell, and D. N. Granger CD40/CD40L contributes to hypercholesterolemia-induced microvascular inflammation Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H689 - H697. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, B. H. Rickman, T. Poutahidis, K. Schlieper, E. A. Jackson, S. E. Erdman, J. G. Fox, and B. H. Horwitz c-Rel Is Essential for the Development of Innate and T Cell-Induced Colitis J. Immunol., June 15, 2008; 180(12): 8118 - 8125. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Kelschenbach, J. Ninkovic, J. Wang, A. Krishnan, R. Charboneau, R. A. Barke, and S. Roy Morphine Withdrawal Inhibits IL-12 Induction in a Macrophage Cell Line through a Mechanism That Involves cAMP J. Immunol., March 15, 2008; 180(6): 3670 - 3679. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bunting, S. Rao, K. Hardy, D. Woltring, G. S. Denyer, J. Wang, S. Gerondakis, and M. F. Shannon Genome-Wide Analysis of Gene Expression in T Cells to Identify Targets of the NF-{kappa}B Transcription Factor c-Rel J. Immunol., June 1, 2007; 178(11): 7097 - 7109. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Filipe-Santos, J. Bustamante, M. H. Haverkamp, E. Vinolo, C.-L. Ku, A. Puel, D. M. Frucht, K. Christel, H. von Bernuth, E. Jouanguy, et al. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production J. Exp. Med., July 10, 2006; 203(7): 1745 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tato, N. Mason, D. Artis, S. Shapira, J. C. Caamano, J. H. Bream, H.-C. Liou, and C. A. Hunter Opposing roles of NF-{kappa}B family members in the regulation of NK cell proliferation and production of IFN-{gamma} Int. Immunol., April 1, 2006; 18(4): 505 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Lee, S. Bennouna, and E. Y. Denkers Screening for Toxoplasma gondii-Regulated Transcriptional Responses in Lipopolysaccharide-Activated Macrophages Infect. Immun., March 1, 2006; 74(3): 1916 - 1923. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mookherjee, K. L. Brown, D. M. E. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F. M. Roche, R. Mu, G. H. Doho, J. Pistolic, et al. Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37 J. Immunol., February 15, 2006; 176(4): 2455 - 2464. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Artis, C. M. Kane, J. Fiore, C. Zaph, S. Shapira, K. Joyce, A. MacDonald, C. Hunter, P. Scott, and E. J. Pearce Dendritic Cell-Intrinsic Expression of NF-{kappa}B1 Is Required to Promote Optimal Th2 Cell Differentiation J. Immunol., June 1, 2005; 174(11): 7154 - 7159. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kim, L. D. Rio, B. A. Butcher, T. H. Mogensen, S. R. Paludan, R. A. Flavell, and E. Y. Denkers p38 MAPK Autophosphorylation Drives Macrophage IL-12 Production during Intracellular Infection J. Immunol., April 1, 2005; 174(7): 4178 - 4184. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki, T. Suda, T. Naito, K. Ide, K. Chida, and H. Nakamura Impaired Toll-like Receptor 9 Expression in Alveolar Macrophages with No Sensitivity to CpG DNA Am. J. Respir. Crit. Care Med., April 1, 2005; 171(7): 707 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pulendran Variegation of the Immune Response with Dendritic Cells and Pathogen Recognition Receptors J. Immunol., March 1, 2005; 174(5): 2457 - 2465. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Raue, J. D. Brien, E. Hammarlund, and M. K. Slifka Activation of Virus-Specific CD8+ T Cells by Lipopolysaccharide-Induced IL-12 and IL-18 J. Immunol., December 1, 2004; 173(11): 6873 - 6881. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Mason, J. Fiore, T. Kobayashi, K. S. Masek, Y. Choi, and C. A. Hunter TRAF6-Dependent Mitogen-Activated Protein Kinase Activation Differentially Regulates the Production of Interleukin-12 by Macrophages in Response to Toxoplasma gondii Infect. Immun., October 1, 2004; 72(10): 5662 - 5667. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Guizani-Tabbane, K. Ben-Aissa, M. Belghith, A. Sassi, and K. Dellagi Leishmania major Amastigotes Induce p50/c-Rel NF-{kappa}B Transcription Factor in Human Macrophages: Involvement in Cytokine Synthesis Infect. Immun., May 1, 2004; 72(5): 2582 - 2589. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Mason, H.-C. Liou, and C. A. Hunter T Cell-Intrinsic Expression of c-Rel Regulates Th1 Cell Responses Essential for Resistance to Toxoplasma gondii J. Immunol., March 15, 2004; 172(6): 3704 - 3711. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Artis, K. Speirs, K. Joyce, M. Goldschmidt, J. Caamano, C. A. Hunter, and P. Scott NF-{kappa}B1 Is Required for Optimal CD4+ Th1 Cell Development and Resistance to Leishmania major J. Immunol., February 15, 2003; 170(4): 1995 - 2003. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Artis, S. Shapira, N. Mason, K. M. Speirs, M. Goldschmidt, J. Caamano, H.-C. Liou, C. A. Hunter, and P. Scott Differential Requirement for NF-{kappa}B Family Members in Control of Helminth Infection and Intestinal Inflammation J. Immunol., October 15, 2002; 169(8): 4481 - 4487. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Butcher and E. Y. Denkers Mechanism of Entry Determines the Ability of Toxoplasma gondii To Inhibit Macrophage Proinflammatory Cytokine Production Infect. Immun., September 1, 2002; 70(9): 5216 - 5224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Caamano and C. A. Hunter NF-{kappa}B Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions Clin. Microbiol. Rev., July 1, 2002; 15(3): 414 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Tato and C. A. Hunter Host-Pathogen Interactions: Subversion and Utilization of the NF-{kappa}B Pathway during Infection Infect. Immun., July 1, 2002; 70(7): 3311 - 3317. [Full Text] [PDF] |
||||
![]() |
C. A. Scanga, J. Aliberti, D. Jankovic, F. Tilloy, S. Bennouna, E. Y. Denkers, R. Medzhitov, and A. Sher Cutting Edge: MyD88 Is Required for Resistance to Toxoplasma gondii Infection and Regulates Parasite-Induced IL-12 Production by Dendritic Cells J. Immunol., June 15, 2002; 168(12): 5997 - 6001. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |